This study shows that PER2 silencing increases the susceptibility of the chemoresistant MDA-MB-231 breast cancer cells to the cytotoxic effects of doxorubicin resulting in S phase arrest and induced apoptosis. The gene discussed is PER2; the disease is breast carcinoma.